| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Eranova Transforming green algae into bio-based resins. Thanks to an innovative and patented solution, our company provides an answer to these two global problems. Our technology uses green macro algae stranded on beaches, a pollutant, as a resource for the production of bio-based, recyclable, compostable resins. This is called Upcycling. Type: | 36 | 13 | 25 | 14 |
 | C4Diagnostics Infectious diseases revealed C4Diagnostics is a French-based biotech specialized in the development of in vitro diagnostic (IVD) tests for human infectious diseases C4Diagnostics' strategy for the better management of Human infectious diseases, is to develop game changing IVD tests which are significantly faster than standard methods whilst maintaining comparable or better performance. Its portfolio currently focuses on the diagnosis of Covid-19 (C4Covid-19), Legionnaires’ Disease (C4Legio LFA), urinary tract infections (C4UTI) and the development of antimicrobial susceptibility tests (C4AST). C4Diagnostics also has a business unit dedicated to environmental diagnostics, called C4Environment. It provides services for the detection of SARS-CoV-2 and other … Type: | 3 | 1 | 1 | 3 |
 | AgenT Detect Alzheimer's earlier, when it could be prevented AgenT is a life sciences company on a mission to defeat Alzheimer’s disease by targeting the silent phase. By combining multi-omics assays with advanced machine learning techniques, we found new blood biomarkers deregulated from the earliest stages of the disease. Using this proprietary database, we are developing accurate blood diagnoses and the next generation of precision therapies to treat Alzheimer’s. ALzheimer's disease, Biotechnology, Diagnosis, Machine learning, and AI Type: | 10 | 2 | 6 | 33 |
 | ADEQUABIO [Automatic translation follows] The science of pollution control Created in early 2018 ADEQUABIO was created following many years of scientific research and the completion of a project as part of the European Life program. The company's core business is the Production and Use of photosynthetic bacteria for the bioremediation of effluents. It markets the Phytobarre device, developed during the Life-Phytobarre project. This is a turnkey station for the treatment of agricultural effluents with photosynthetic bacteria. Also wanting to diversify its fields of activity, ADEQUABIO explores new avenues and also participates in research projects. For example, the VESPA Project which aims … | 2 | 2 | 0 | 4 |
 | Abolis Biotechnologies Decipher - Innovate - Build Abolis is a French company developing high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 50 people, sharing a scientific and humanist ambition. Determined to become a key player in the ecological transition, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries make … Type: | 11 | 1 | 11 | 42 |
 | GenoSplice technology GenoSplice provides high-level Bioinformatics services for Genomics projects. Our organisation is leader in next generation sequencing and microarray data analysis, with specific expertise in alternative splicing. Our main goals are: • allowing to manage a huge quantity of data from your laptop with our dedicated platform, • turning raw complex data into easy-to-interpret biological information. Bioinformatics, Alternative Splicing, Sequencing, and RNA-Seq Type: | 2 | 2 | 0 | 8 |
 | Epigene Labs augmented intelligence for precision oncology research and drug development Epigene Labs is creating the intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company's mCUBE platform accelerates data-driven drug discovery, biomarker identification, and patient selection -- to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs was initially incubated at the Harvard Innovation Labs and launched in France with the support of prominent European investors. Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies. Type: | 5 | 3 | 4 | 27 |
 | Mentalista Join the Mentalista Club to develop brain-enabled products and services that prepare the future needs of users. Mentalista is a deeptech company created in 2017, specializing in brain-environment interfaces. Our goal is to empower everyone with a more instinctive technology. We create a new language using brainwaves in which users' thoughts allow them to interact with their connected environment. Moving an object, turning on a light, going to the next track, ect., these simple gestures that today require physical action are now within the reach of the brain. A new interface, offering users a wealth of new applications and providing … Type: | 6 | 2 | 6 | 5 |
 |  Biomanda [Automatic translation follows] Created in September 2013 by Julien Gardès, Biomanda offers bioinformatics services specializing in the detection and studies of microbial biodiversity. Develop a PCR (Polymerase Chain Reaction) or qPCR detection solution to target any microorganism or virus. Improve your PCR detection solutions for maximum specificity and sensitivity. Benefit from new generation microbial biodiversity studies (metagenomics) to know with great precision the effect of a product on the microbial flora of an environment or living tissue. We also analyze all types of biological data with the possibility of carrying out data-mining steps (i.e. searching for additional information on the … Type: | 0 | 0 | 0 | 1 |
 |  Archimej Technology ARCHIMEJ TECHNOLOGY is an innovative French start-up, developing, protecting and promoting a disruptive technology: SPECTROSCOPY 2.0®. Based on three optical innovations patented and on a committed and talented team, the SPECTROSCOPY 2.0® is a technology enable to achieve absorption spectrometers with properties never seen before, especially in terms of measurement sensitivity, miniaturization and manufacturing costs. The SPECTROSCOPY 2.0® can be used in different markets such as In-Vitro Diagnostic, where it has serious competitive advantages on mature applications such as Biochemical Analysis (Clinical Chemistry Analysis). It has also advantage on the emerging technologies like Point of Care. | 0 | 0 | 0 | 1 |
 | ErVimmune Targeting shared unconventional tumor antigens in cancer immunotherapy R&D oncology | 1 | 1 | 0 | 17 |
 | ACS Biotech [Automatic translation follows] The cartilage repair solution ACS Biotech Develops Innovative, Reliable, Durable Injectable Cartilage Repair Solution to Treat Cartilage Injuries Type: | 13 | 5 | 7 | 7 |
 | Quantificare QuantifiCare is a fast growing leading Imaging CRO offering: - Pre-clinical to phase IV clinical trial services across a wide range of clinical areas to pharmaceutical, biotech and cosmetic industries. - Innovative imaging tools tailored for medical specialists including plastic surgeons, aesthetic specialists and dermatologists. Type: | 1 | 1 | 0 | 137 |
 | Skymab Biotherapeutics Make mAbs move mountains | 0 | 0 | 0 | 10 |
 | APTEEUS Reconcile the time of Research with the one of Medecine APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured. Type: | 0 | 0 | 0 | 10 |
 | Adverum Biotechnologies We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss. Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its … Type: | 0 | 0 | 0 | 141 |
 | ZEDIRA GmbH Targeting Transglutaminase for Research & Medicine! ZED1227 First Tissue Transglutaminase Inhibitor in Clinical Trials! Zedira is specialist and global brand for transglutaminase. More than 200 specialty reagents for transglutaminase-related R&D. Researchers from academia and industry (including 12 of the top 15 big pharma companies) benefit from Zedira’s cutting edge products – and in an increasing manner – from customised services. Solutions for site specific labeling of proteins using transglutaminases form Zedira’s latest product field. Simply - "The Transglutaminase Company" and From bench to bedside Type: | 0 | 0 | 0 | 10 |
 | microDimensions microDimensions was founded as a spin-off of the Technical University of Munich in 2011 as a provider of integrated and efficient software solutions and services for digital pathology applications. Our mission is to shape next generation pathology by connecting human expertise with artificial intelligence and by facilitating clinical and scientific exchange. Our clients are MedTech and Life Science companies who aim for advancing diagnosis. They look for enriched data to unlock the full power of computational pathology and to share their latest advancements with the medical community. With our #DigitalPathologyHub Anyslide (https://anyslide.com) pathologists can share histology images instantly and vendor … Type: | 0 | 0 | 0 | 1 |
 | Precision BioSciences, Inc. Dedicated to Improving Life. Precision BioSciences, Inc. (Nasdaq: DTIL) is a pre-clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com. Gene Editing and Gene Therapy Type: | 2 | 1 | 1 | 124 |
 | OakLabs Scientific Reach New Heights With Your Biomarkers At OakLabs Scientific, we believe that each of us can live longer healthy. In a society where individual healthcare is increasingly challenging, we are pioneering ways to detect and avert disease before it occurs. Using our unique Artificial Intelligence algorithms and high-molecular-weight data, we are exploring individual health status in unprecedented depth. gene expression analysis, biotechnology, research, biomarkers, biomarker signatures, and companion diagnostics Type: | 0 | 0 | 0 | 10 |
 | ChromoTek new tools for better research #newtoolsforbetterresearch Part of Proteintech Group. ChromoTek pioneered the development and commercialization of alpaca Nanobodies. As a market and product leader for high quality and reliable Nanobody-based reagents, we assist scientists’ research world-wide. In addition, ChromoTek is a trusted service provider of custom-made Nanobodies for the pharmaceutical industry. Founded in 2008 ChromoTek has offices in Martinsried, Germany, and Hauppauge, NY. In contrast to traditional antibodies Nanobodies consist of only one single polypeptide chain; they are 15 kDa and the smallest antibodies known. ChromoTek GmbH, Affinity purification, Immunoprecipitation, Co-IP, Mass spectrometry, Ligand capture, Protein-protein interaction, GFP-Trap, Fluorescent … Type: | 0 | 0 | 0 | 16 |
 | Veracyte, Inc. High-value insights, high-impact decisions Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our growing menu of diagnostic tests answers important clinical questions to help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment. | 4 | 3 | 1 | 561 |
 | VectorBuilder VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to … Type: | 1 | 1 | 0 | 73 |
 | Kiyatec Inc. Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and … Type: | 1 | 0 | 1 | 25 |
 | Seres Therapeutics Leading the Microbiome revolution Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in … Type: | 3 | 1 | 1 | 329 |
 | BioVersys AG Leadership in overcoming the antibiotic resistance crisis. BioVersys AG is a privately-owned clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company’s award-winning TRIC technology we can overcome resistance mechanisms, block virulence production and directly affect the pathogenesis of harmful bacteria, towards the identification of new treatment options in the antimicrobial and microbiome fields. By this means, BioVersys addresses the high unmet medical need for new treatments against life-threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. Our … | 1 | 0 | 1 | 24 |
 | MRM Health Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition … Type: | 1 | 1 | 0 | 49 |
 | OPPILOTECH LTD Navigating Biology, Discovering Drugs Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the models to simulate biological processes in order to identify viable drug targets and discover new biology. The company is building a pipeline of first-in-class drug discovery programmes based on the identified targets. Type: | 1 | 1 | 0 | 10 |
 | PEPperPRINT GmbH The leading provider of high-density peptide microarrays for antibody validation, epitope mapping & antigen discovery. PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by … Type: | 0 | 0 | 0 | 23 |
 | GQ Bio Therapeutics High-Capacity Gene Therapy Vector Platform to Address Prevalent Diseases GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. biotechnology, gene therapy, osteoarthritis, drug development, human … Type: | 0 | 0 | 0 | 15 |
 | siTOOLs Biotech GmbH High Specificity Tools for RNAi, rRNA depletion & RNA Interactome Studies. Services: Making Sense of RNAi Screening Data We drive RNA research with tailored molecular tools. We are from Munich and provide researchers with highly complex & advanced genetic tools. Our core expertise is RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq. Distinguished by their exceptional targeting specificity and efficiency, our gene function analysis tools include - siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion. Our technology combines high complexity oligo pooling (“Pack Hunter” approach), proprietary design … Type: | 0 | 0 | 0 | 10 |
 | CYTENA We make the development of modern therapies faster, safer, and more affordable. Join us to create the future of health! We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other … Type: | 0 | 0 | 0 | 77 |
 | Quantgene We are on a mission to KILL CANCER with Intelligent Genomics. Quantgene is on a mission to detect and end cancer early with Intelligent Genomics. By making genomics intelligent, we can now detect and eliminate cancer at the earliest stages. Universal early detection of cancer can reduce mortality rates up to 80% and end cancer as we know it. Cancer diagnostics, biotechnology, genomics, machine learning, oncology, precision medicine, cancer screening, deep sequencing, cancer, innovation, AI, and Cancer Detection Type: | 3 | 0 | 3 | 43 |
 | Renovatio Biomédica [Automatic translation follows] Renewing the Concept of biomedical projects. Renovatio Biomédica is a consulting firm specialized in the design, management and development of multidisciplinary projects, training and communication in biomedicine. We generate ideas and proposals with added value for your company or project, always seeking excellence in all phases. Our key: Teamwork and STRATEGIC VISION. Experts in multidisciplinary projects: We generate the base idea of the project with the advice of experts in different fields of biomedicine, based on your objectives, we coordinate the work of the participating specialists, we develop the work plan and edit the deliverables configured in … Type: | 0 | 0 | 0 | 4 |
 | CellSine Discover your favorite frequencies to boost your drug discovery business CellSine provides devices and software that make advanced electrochemical impedance spectroscopy easily accessible to any microbiological researcher. It delivers a platform tool for a that enables a wide variety of biochemical studies. Biotechnology, Cell culture monitoring, Proteïn - Proteïn interactions, Suspension cultures, Receptor signaling, Biofilm maturation, and T lymphocyte activation Type: | 1 | 1 | 0 | 4 |
 | Integrated Micro-Chromatography Systems A leader in recombinant enzymes and automated micro-chromatography technologies About Integrated Micro-Chromatography Systems, Inc. At Integrated Micro-Chromatography Systems (IMCS), we strive to address the growing needs of clinical and research laboratories through advanced technologies that increase testing efficiency. IMCS products help to drive the future of precision medicine. We understand the importance of accuracy, which is why we are committed to delivering products that consistently provide fast, reliable results. Company History Integrated Micro-Chromatography Systems, Inc (IMCS) was founded in January 2013 by three scientists from the University of South Carolina. IMCS designs, develops, manufactures, and distributes next-generation recombinant proteins and … Type: | 1 | 0 | 1 | 29 |
 | Floreon Innovative plant-based bioplastic, redefining PLA. Floreon revolutionises sustainability in plastics. Derived from crops like corn and sugar cane it offers a sustainable alternative to conventional oil-based plastics. With a significantly lower carbon footprint up to seven times less than traditional plastics such as ABS, PC, or HIPS. While traditional engineering plastics are made from fossil resources, Floreon harnesses the power of plants by transforming Polylactic Acid (PLA) into a durable engineering polymer. Unlike typical PLA, often limited to disposable uses, Floreon's pioneering technology elevates it for durable applications and is available in three advanced products engineered to meet your specific … Type: | 1 | 0 | 2 | 5 |
 | mjn-neuro Quality of life for people with epilepsy mjn-neuro is a company dedicated to the design, manufacture and commercialization of medical devices with the aim of improving people's quality of life. All this activity is accompanied by an important policy of reinvestment of resources in R&I and social action. The first device that mjn-neuro is developing is mjn-SERAS: an earpiece that assesses the risk of epileptic seizures. The product consists of the earpiece and an app, which are connected to each other via Bluetooth. The earpiece is customised for each user. The main function of the earpiece is to send a … Type: | 10 | 3 | 8 | 22 |
 | Ossium Health The Greatest Wealth is Health Building a Healthier Future Our mission is to improve the health, vitality, and longevity of human beings through bioengineering. Who We Are At Ossium, we believe that science is humanity’s best weapon in the fight against disease, and we embrace the challenge of mobilizing the world’s healthcare ecosystem to win that fight. In pursuit of this goal, we empower our employees, maintain the highest standards of excellence, and are a force for good. PRINCIPLES The values we live by Impact We are mission-driven and results-oriented. We believe that a healthier world is a better one … Type: | 2 | 0 | 2 | 101 |
 | Koatum An innovative solution for medical implants Koatum is a MedTech startup that developed a medical implant coating technology for dental and orthopaedic implants. Koatum prevents inflammation and accelerates bone integration, for a faster, painless recovery. Technology provides opportunity to coat any materials which could not be coated with plasma sputtering due to the high temperatures involved. An inert first layer is ensuring perfect formation between implant and coating. Upper layers, made from hydroxyapatite without the intense heat used in plasma coating, remain bioactive and durable. Technology also provides the ability to implement drug delivery systems. With Koatum technology surgeon can … Type: | 0 | 0 | 0 | 3 |
 | Cirqle Biomedical Zero compromise contraception. We combine human-centred design & mucus engineering to launch a new era in contraception. Cirqle Biomedical combine human-centred design and mucus engineering to launch a new era in contraception. Type: | 1 | 1 | 0 | 15 |
 | Cyclica (acquired by Recursion, Nasdaq: RXRX) From molecule to medicine Unlocking the protein universe to discover the medicines of tomorrow Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter. Drug Development, Network Pharmacology, Drug Repositioning, Proteomics, Clinical Trials, Side Effects, Bioinformatics, Systems Biology, Drug Discovery, Artificial Intelligence, polypharmacology, medicines, Machine learning, pharmacology, pharmaceuticals, and bioinformatics Type: | 15 | 2 | 11 | 8 |
 | PDC*line Pharma A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line) Founded in 2014 as a spin-off of the French Blood Bank (EFS), PDC*line Pharma is a French-Belgian biotech company that develops an innovative class of active immunotherapies to treat cancers. This cancer vaccine contains proprietary, potent, and scalable plasmacytoid dendritic cell line (PDC*line), whose remarkable characteristics make them excellently suited for immunotherapy. PDC*line is much more potent to prime and boost antitumor antigen, including neoantigens, specific cytotoxic T-cells than conventional vaccines and improves the response to checkpoint inhibitors. PDC*line offers unique advantages: - PDC*line … Type: | 9 | 1 | 4 | 37 |
 |  BioNTech SE Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. To pioneer the next generation of patient-specific immunotherapies, we have combined ground-breaking research with cutting-edge technologies to develop therapeutics for cancer and beyond. Our broad and synergistic suite of platforms, which include mRNA therapeutics, engineered cell therapies, antibodies and small molecule immunomodulators have been optimized for distinct modes of action, high precision targeting, high potency and efficacy. We are also developing … Type: | 38 | 17 | 8 | 4,420 |
 | IDbyDNA Precise Insights for Better Health Delivering on our promise to identify any microbe, from any sample, anywhere in the world will take a team of dedicated, passionate, and experienced individuals. The members of our team at IDbyDNA have a strong track record of building successful organizations and bring a breadth of multi-disciplinary experience including; microbial genomics, bioinformatics, software engineering, laboratory medicine, and commercialization. In concert with the global community of researchers, clinicians, industry partners and policy makers, we will revolutionize microbial detection and bring new solutions to solve problems that are not currently addressable with today’s technologies. Type: | 3 | 0 | 3 | 27 |
 | Wave Life Sciences Unlocking the broad potential of RNA medicines to transform human health Wave Life Sciences is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Our RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Our toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing us with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Our diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency … Type: | 5 | 3 | 3 | 309 |
 | Roka Furadada Smart active ingredients, safer sun exposure Catalonia Exponential Leader 2023 Roka Furadada’s mission is to reduce the incidence of skin cancer through research, development and production of active ingredients and medical devices, with high efficiency and low toxicologic and environmental impact OUR PURPOSE Roka Furadada wants to help to prevent and reduce the incidence of skin cancer. HOW ARE WE GOING TO DO IT? Developing the first intelligent ultra violet radiation filter: SMART UV, with new molecules that entail therapeutic activity to prevent and treat diseases associated with sun exposure. Cosmetics, Raw Materials , Ingredients, Cosmetic Ingredients, Sunscreen, Sun protection … Type: | 5 | 1 | 5 | 28 |
 | Figura Analytics Limited Revolutionising liquid analysis - protecting people and products Figura’s new platform nanopore technology rapidly characterises, identifies and quantifies particles in liquids. Helping to save time and money in a number of sectors. Our technology uses our propitiatory microfluidics, sensors and software algorithm and we can characterize any particle suspended in a solution, regardless of its size and sample matrix, allowing healthcare practitioners to act fast and manufacturers to take corrective action earlier in the production process. Type: | 0 | 0 | 0 | 5 |
 | Dualyx Discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. We aim to create long-lasting treatments for patients with a high unmet medical need. | 0 | 0 | 0 | 17 |
 | Floating Genes Early cancer diagnosis in liquid biopsy by ultra-sensitive ctDNA sequencing. Early cancer detection from liquid biopsies | 7 | 6 | 1 | 4 |
 | AIOVA [Automatic translation follows] Vaccines for the future Based on innovative, patented technology, AIOVA aims to develop and market innovative vaccines, with high added value, to its pharmaceutical industrial clients. AIOVA is positioned in the fight against emerging or re-emerging and deadly pandemics of humans and animals, in a OneHealth approach, and in particular influenza (human and avian influenza), AIDS-type diseases, and, very recently , diseases caused by coronaviruses such as SARS-CoV-2, responsible for the current COVID-19 pandemic. The vaccines are designed using a patented DNA platform and have the properties of activating, in the vaccinated host, not only the production … Type: | 0 | 0 | 0 | 1 |
 | GenSensor GenSensor - a biotech/deeptech company - develops and provides in-line sequencing systems for bioproduction | 7 | 3 | 5 | 11 |
 | Vaxinano Innovation for Human and Animal Health Protection Vaxinano: a new-generation vaccine platform. Vaxinano is a biotechnology company based near Lille, specialising in the development of prophylactic and therapeutic vaccines to combat infectious diseases in animal and human health. We offer a vaccine platform from which innovative non-adjuvanted vaccines are developed. This platform not only makes it possible to develop new vaccines and improve existing vaccines (by replacing adjuvants), but also to reduce or even replace the use of antibiotics. The patented technology is based on biosourced nanoparticles (starch and lipids) manufactured according to the principles of green chemistry and Good … Type: | 5 | 2 | 4 | 14 |
 | Evexta Bio Evexta Bio, formerly #Diaccurate, is a biopharmaceutical company exploring the new frontiers of #oncology in search of daring novel therapeutic approaches with the potential to save lives. Now in the clinic, the French biotech is currently developing two proprietary therapeutic assets with novel mechanisms of action across several indications: - Rupitasertib, formerly DIACC3010, an optimized S6K inhibitor with efficient AKT1/AKT3 control of feed-back loop. The oral anti-tumor agent is expected to enter phase 2/3 clinical trial in refractory ER+ HER2- metastatic breast cancer. - EVX020, formerly DIACC2020, an antibody-drug conjugate program using a sole-in-class KIF20A kinesin inhibitor as payload in … Type: | 4 | 0 | 4 | 14 |
 | MICROBIA ENVIRONNEMENT Prevent today and anticipate tomorrow microbiological risks in aquatic environments In the context of climate changes and diverse pollutions, waterborne microbial threat has been increasing during the last decades causing billion Euros of direct and indirect economic losses worldwide. Unfortunately, the current monitoring programs which are essentially based on microscopic observations and analytical chemistry, are not suited to anticipating risks and give results when already to late to act. Microbia Environnement is a biotech company founded in 2013 which aims to bring a unique selling proposition to give stakeholders a step ahead for timely water management actions to protect end-users, … Type: | 23 | 7 | 9 | 7 |
 | Vetbiobank Leading Animal Cell Therapy - Improving Animal Healthcare. Vetbiobank is a biotech company specialized in veterinary regenerative medicine. For our customers and their animal companions (dogs, cats, horses), we are leveraging the unique biological potential of neonatal stem cells. Those stem cells deliver locally an appropriate set of bioactive messages to organise and promote the harmonious healing of injuries or dampen inflammatory chronic diseases. Funded in 2011, Vetbiobank has built its expertise on the experience of its founder, former expert in human cell therapy development, and cord blood derived stem cells. The mission of Vetbiobank is to provide veterinarians with … Type: | 1 | 1 | 0 | 10 |
 | Inventiva Pharma A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc Type: | 1 | 1 | 0 | 117 |
 | Cyprio Created in 2017, Cyprio is founded on ten years of research at the prestigious French institute for higher education in science and engineering, Ecole Supérieure de Physique et Chimie Industrielles de la ville de Paris (ESPCI Paris), with a strong expertise in the field of 3D cell culture, liver biology and drug development. This makes Cyprio the holder of a unique technology for fabrication of alginate liquid-core capsules containing 3D cellular models physiologically more relevant than traditional monolayer cell culture and compatible with high throughput screening applications. Our first product "HepatoPearl" has been validated as a beneficial in vitro liver … Type: | 2 | 1 | 2 | 11 |
 | MagIA diagnostics Your immunoassay: Faster, Simpler, Accessible MagIA is developing a multi-analyis "Point-of-Care" that can be used outside of any clinical environment. With a first focus on infectious diseases MagIA is providing a syndromic testing approach at the Point of Care outside of traditional clinical environment. With the motto “a better screening for a better care", MagIA focuses first on the rapid detection of infectious diseases, starting with an HIV-Viral Hepatitis combo, to link to care Key « high-risk » populations. MagIA's innovation is a one-step no-wash immunoassay method which brings unique characteristics: (1) laboratory quality on a portable device, usable indoor, … | 8 | 6 | 4 | 17 |
 | Antofénol [Automatic translation follows] Our vision: Obtain the best from the plant, without using conventional chemical solvents. Our expertise: - Simultaneously exploit 4 proven eco-extraction technologies. - Provide solutions for the development of your ingredients in order to enrich your range of active biomolecules (polyphenols, flavonoids, alkaloids) Our objective: To offer eco-responsible solutions to enable you to respond to future ecological and economic challenges. vacuum distillation, Vegetable eco-extraction, R&D, objectified ingredients, microwave, Ultrasound, Atomization, Lyophilization, Grinding, Natural extracts, Active ingredient, 100% natural active ingredients, eco responsible, polyphenols, essential oils, cosmetics, perfumery, nutraceuticals, and agro-food Type: | 8 | 3 | 6 | 18 |
 | Amoéba Fight pathogens, Respect nature Founded in 2010, Amoéba is an innovative industrial biotech specialised in the treatment of microbiological risk of natural resources. Our biosolutions are based on a unique micro-organism, the amoeba Willaertia magna C2c Maky. Thanks to our scientific, industrial and commercial know-how, we are able to provide biological alternatives for different applications and industries. OUR SOLUTIONS 💧 Biocide "BIOMEBA": This historical application, initiated at the foundation of the company, enables the treatment of water in cooling towers and uses the amoeba Willaertia magna C2c Maky in its living form. In 2022, the US EPA has approved the … Type: | 8 | 2 | 0 | 36 |
 | LYSOGENE Improve the lives of children with CNS diseases Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children. Founded in 2009 by Karen Aiach, whose own child was affected by a neurodegenerative disease, Lysogene is rooted in a deep and compassionate understanding of the impact these diseases have on patients and families. Karen’s personal experience fuels her determination to deliver real solutions that will improve patient outcomes and enhance quality of life for both patients and caregivers. Over the past 10 years, Lysogene has acquired deep experience in developing gene therapies—from early … Type: | 7 | 5 | 0 | 10 |
 | Causeway Therapeutics Healthy Ageing Through Musculoskeletal Health Maintaining musculoskeletal health is the keystone of overall health as we get older. As we age our physical condition gradually deteriorates, leading to loss of strength, fitness and mobility. In most cases, this isn’t due to a simple decision to stop exercising. It is due to the breakdown of musculoskeletal function caused by disease. Musculoskeletal diseases such as osteoarthritis, tendinopathy and lower back pain are the primary causes of disability and early retirement in people over the age of 65. Currently, there are no approved disease-modifying drugs for these diseases, meaning that physical decline in … Type: | 2 | 0 | 1 | 7 |
 | ToxGenSolutions BV (TGS) Epigenetics-based diagnostics, prognostics and preventative therapeutics for high-impact chronic pathologies. ToxGenSolutions (TGS) applies toxicogenomic approaches on human health problems to provide the customer with epigenetic biomarker fingerprints for application in novel, more accurate, methods for the particular diagnosis of their need. TGS aims to develop novel and innovative epigenetic profiles hallmarking high-impact chronic and rare neurodevelopmental diseases to serve as early, preclinical, diagnostic verdicts of a disease. With the development of these novel tools, TGS aims to bridge the frequently large gap towards disease progression and therapeutic intervention. TGS provides novel epigenetic diagnostic methods for the early identification of pressing … Type: | 0 | 0 | 0 | 7 |
 | Deep Lens Accelerating clinical trial matching in oncology Deep Lens is a digital healthcare company focused on enabling faster recruitment of the best-suited cancer patients for clinical trials at the time of diagnosis using VIPER. Deep Lens’ AI-driven cloud platform gives care teams, trial coordinators and oncologists visibility into all available trials and the ability to collaborate on groundbreaking cancer research across all cancer types. Artificial Intelligence, Pharmaceuticals , Cancer Research, Oncology, and Pathology Type: | 4 | 1 | 3 | 5 |
 | Olaris, Inc Removing the Guesswork from Medicine Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARISTM diagnostics products, which aim to optimize treatments and outcomes for individual patients. Metabolite diagnostics empower therapeutic selection, treatment effectiveness monitoring, disease diagnosis, and target identification across indications and therapeutics areas, including oncology, solid-organ transplant, and neurodegeneration. Our mission is to remove the guesswork from medicine. Diagnostics, Machine Learning, Metabolomics, NMR, Mass Spectrometry, Statistics, Transplant, and Oncology Type: | 1 | 1 | 1 | 14 |
 | HP Health Solutions Germany GmbH For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology Type: | 0 | 0 | 0 | 23 |
 | Solaga [Automatic translation follows] Solaga - Living Walls Solaga is a spin-off from Humboldt University and is concerned with using robust microalgae systems to improve air quality. We are a startup from Berlin that develops algae systems for better air and energy. With our algae image and numerous projects, we pursue the vision of covering the world with a green carpet of algae to improve the health and general well-being of people indoors and outdoors. Subject areas: - self-sufficient/biological air purification through algae growth in the interior - high-quality air filter systems for urban and production areas - Innovative wall decorations … Type: | 5 | 0 | 4 | 12 |
 | IMET - Institute of Marine and Environmental Technology Baltimore Sun's Top Workplaces List: 2019-2021 The Institute of Marine and Environmental Technology (IMET) is a joint University System of Maryland research institute capitalizing on the strengths of the University of Maryland Center for Environmental Science, the University of Maryland Baltimore County and the University of Maryland Baltimore. IMET utilizes the research, training and technology transfer capabilities of these partner institutes to further its mission. The scientists at IMET conduct marine and environmental research and thereby create technologies designed to foster the protection and restoration of coastal marine systems and their watersheds, sustainable use of their resources and improvement of … Type: | 0 | 0 | 0 | 42 |
 | Science Entrepreneur Club Building communities. Enabling innovation. Connecting the life science ecosystem. We’re a non-profit on a mission to build meaningful communities to enable innovation and connect the life science ecosystem. We're building communities for entrepreneurs building in bio, investors actively backing life science companies and academics looking to break into industry. The SEC is the home of the BioFounder Club, BioCapital Network and BioAcademic Hub. entrepreneurship, innovation, science, engineering, life science, biotech, startup, networking, technology, and health Type: | 10 | 0 | 11 | 25 |
 | Biodexa Pharmaceuticals PLC Advancing Medicines for a Brighter Future Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain. The Company’s lead candidate, MTX110, is being studied in aggressive rare/orphan brain cancer indications including recurrent glioblastoma and diffuse midline glioma. MTX110 is a solubilised formulation of the histone deacetylase (HDAC) inhibitor, panobinostat. This proprietary formulation enables delivery of the product via convection-enhanced delivery (CED) at potentially chemotherapeutic doses directly to the site of the tumour, by-passing the blood-brain barrier and avoiding systemic toxicity. | 0 | 0 | 0 | 23 |
 | ABLE - Association of Biotechnology Led Enterprises The Collective Face of the Indian Biotechnology Industry Association of Biotechnology Led Enterprises - ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology Sector. It was launched in April 2003, after industry leaders felt a need to form an exclusive forum to represent the Indian Biotechnology Sector. ABLE has members from all across India representing all verticals of the sector like agribiotech, bio-pharma, industrial biotech, bioinformatics, investment banks and Venture Capital firms, leading research and academic institutes and law firms and equipment suppliers. The primary focus of ABLE is to accelerate the pace of growth of the Biotechnology … Type: | 2 | 1 | 1 | 17 |
 | Modul-Bio Solutions dedicated to Biobanking: and sample repositories. Manage and track all your biological samples! Created in 2003, Modul-Bio is an innovative company specialized in IT solutions for biological sample management providing barcoding systems, LIMS (Laboratory Information Management System) software and collaborative tools for sharing biological sample collections. LIMS, Biobanks, Traceability, Sample management, Biobanking, and Cohort Type: | 1 | 1 | 0 | 23 |
 | ANS Biotech Our Services are as Unique as Your Discoveries ANS Biotech, a preclinical CRO dedicated to pain pharmacology, supports drug discovery and development efforts of companies involved in human and animal health, food and nutrition, by providing them with: • Clinically relevant in vivo models for successful R&D of innovative analgesics, especially in the field of inflammatory pain, neuropathic pain and visceral pain ; • Customized scientific studies meeting drug discovery and development objectives ; • Consulting activities. ANS Biotech also offers ALGOGramTM, a unique in vivo screening tool that provides a rapid and cost-effective means to systematically explore pain indications … Type: | 2 | 2 | 0 | 22 |
 | Abcell-bio Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for … Type: | 1 | 1 | 0 | 10 |
 | Quartolio Quartolio is an autonomous insight discovery platform that makes sense of millions of scientific documents in real-time Quartolio is an autonomous insight discovery platform that makes sense of millions of scientific documents in real-time for better outcomes and greater impact. We bring Moonshots Within ReachTM️ for the 10M+ science professionals around the world. Education Technology, Data Science, Artificial Intelligence, and Biotechnology Type: | 4 | 0 | 4 | 3 |
 | Personalized Stem Cells, Inc StemInsure®: Your Younger Cells For Life® Personalized Stem Cells, Inc. (PSC) is raising the standard of Stem Cell therapy. We are committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and patients. Type: | 0 | 0 | 0 | 5 |
 | Orphazyme A/S Our vision: To profoundly impact the lives of patients with orphan diseases and their families Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases. Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our … Type: | 2 | 0 | 1 | 14 |
 | Duplaco B.V. Reliable chlorella algae producer in the EU Duplaco, based in the Netherlands, reinvented farming to grow clean and rich Chlorella microalgae in a 100% closed system, without disturbing nature. These microalgae are packed with protein, fibers, vitamins, minerals and antioxidants. Big impact, tiny footprint. Microalgae, Biotechnology, Aquaculture, Food supplements, Feed, Tailor made, Fresh, Functional ingredient, Chlorella, Algae, Vegan, and Protein Type: | 4 | 0 | 4 | 26 |
 | De Novo Foodlabs Pioneering the future of nutrition. De Novo Foodlabs is a pioneering biotech start-up revolutionising the field of nutrition. Leveraging the power of microbial fermentation, the company creates innovative products that promote better health for both people and the planet. Food design, Product Development, Recombinant proteins, nutrition, health, and alternativeproteins Type: | 1 | 1 | 1 | 11 |
 | Floré by Sun Genomics The Best Custom Probiotics For A Healthy Gut are the Ones Made Specifically For You. The microbiome is the new frontier gut health and changes to your microbiome signature is now being understood as a central conduit of health and disease. IBD, IBS, Crohn's, colitis, type I diabetes, arthritis, metabolic syndrome, and several autoimmune disorders have all been associated with microbiome changes also known as dysbiosis. When you total the number of individuals affected by these diseases, over 80% Americans suffer from dysbiosis annually. With this much science there still aren't real solutions for dysbiosis. And since dysbiosis is the … Type: | 1 | 0 | 1 | 22 |
 | Nourish Ingredients We create delicious with our potent animal-free fats for a more delicious and sustainable food system. Nourish Ingredients is a revolutionary food tech company creating potent, animalic fats to make plant proteins delicious. Combining breakthrough science with a focus on the most potent fat molecules found in nature, they are changing the plant protein market by creating the authentic taste, smell and cooking experience people want and expect - without the animal. Type: | 1 | 1 | 1 | 46 |
 | Avant Gratify Without Sacrifice: Technology for cleaner & more sustainable marine proteins Avant is the first cultivated fish company in Asia, with operations in Singapore and Hong Kong. Thanks to Avant's technology, we will be able to have fish meat without killing fish. Our cultivated fish products are more nutritious than conventionally produced fish, GMO-free, and pollutant-free. The pilot product focus of Avant's technology platform is fish and seafood tailored for the food culture of consumers in China and Asia. biotech, cultivated meat, and alternative protein Type: | 5 | 1 | 3 | 26 |
 | Shiru Shiru is creating the next generation of sustainable ingredients. We're powered by Flourish, our AI discovery engine. Shiru is an AI-enabled company developing performance ingredients for people and planet. Type: | 5 | 1 | 4 | 28 |
 | Amulet Understand the Unseen Amulet is shining a light on invisible threats in our food system. Amulet has two brands: Allergy Amulet, whose signature wearable alerts people to allergens in their food; and Amulet Scientific, which equips food manufacturers with technology to target toxins and contaminants. | 1 | 0 | 1 | 17 |
 | Grown.bio We grow 100% natural alternative to plastic foam, transforming packaging, interior& architecture worlds. #MycoComposite We are replacing fossil-fuel based Styrofoam with our 100% natural innovation Mycelium Packaging . Working together with our customers, we work to leave a better world for the future. Mycelium is a natural material, the root structure of mushrooms. It has similar qualities to Styrofoam (EPS) in terms of protection and is ideal for protective packaging as well as interior design products and insulation. Possibilities are limitless and we are expanding our horizon every day! Get in touch to become one of the pioneers who make … Type: | 1 | 0 | 1 | 10 |
 | Innomy Innovation & Mycology | Empowering The Fungi World Innomy develops global solutions for the food industry such as meat analogues or functional flours, always using sustainable biotechnological processes based on fungal mycelia and revaluing by-products from various industries as raw materials. Mycelium, Nutrition, Food Tech, Wet Protein, Functional Flours, Meat Analogues, Fungi , Biotech, Healthy Food, Umami, Sustainable, Science, Natural Products, Protein, Food Industry, By-products, Functional Food, Super Food, Fungi Based Meat, Fungi Meat, Fungi Food, and Mushroom Meat Type: | 3 | 1 | 3 | 9 |
 | Chi Botanic We're developing the world's first synthetic biology pipeline to leverage the power of the plant cell. #IndieBio class 9 The Plant Cell Company! Type: | 0 | 0 | 0 | 2 |
 | Sway Materials that replenish the planet, from sea to soil. Sway is a cleantech startup scaling seaweed-based, rapidly compostable replacements for plastic, beginning with flexible packaging. Our patented products match the vital performance attributes of conventional plastics and are designed to plug into existing infrastructure, enabling scale and competitive pricing. Unlike plastic, however, our materials are made from an abundant, regenerative resource and decompose into healthy soil after use. In 2023, Sway won first place in the TOM FORD Plastic Innovation Prize. In 2021, Sway also won the Beyond the Bag Challenge sponsored by Closed Loop Partners and a consortium of … Type: | 10 | 1 | 9 | 21 |
 | myNEO Therapeutics Innovating immunotherapies, transforming tomorrow. myNEO Therapeutics is a distinguished biopharmaceutical powerhouse, dedicated to pioneer breakthrough immunotherapies to fight cancer. myNEO Therapeutics is leveraging its ImmunoEngine discovery platform to tap into novel promising tumor targets found in the dark genome – named camyotopesTM – which have the potential to unlock immunotherapy for large patient populations who currently do not respond. In parallel, the service angle of myNEO Therapeutics, myNEO Intelligence, assists biopharma companies in transforming their decision-making process from trial & error to data-driven decisions using an AI-powered platform. Deriving insights from its expansive library of clinical and molecular data, myNEO … Type: | 3 | 1 | 3 | 18 |
 | EyeD Pharma Delivery of vision care EyeD Pharma is a clinical stage pharmaceutical company dedicated to improving the life of patients suffering from ophthalmic diseases with unmet medical needs such as glaucoma or dry eye. We develop innovative therapeutic solutions based on sustained release polymeric micro-implants and inserts. Type: | 4 | 1 | 4 | 70 |
 | Ukko On a mission to solve food allergies and sensitivities Ukko is improving the lives of millions that suffer from food allergies and disorders. We are using cutting edge technologies in immunology, computational biology, and plant science to develop a new approach. We have offices in Tel Aviv, Israel and Palo Alto, California. Type: | 0 | 0 | 0 | 64 |
 | Infinant Health We're changing the trajectory of human health, one baby at a time. Intent on a world without debilitating disease. Infinant Health, Inc is a privately held company committed to changing the trajectory of human health, one baby at a time, through our deep understanding of infant nutrition and the gut microbiome. Years of proprietary research into the role of breast milk and its impact on human development led to our groundbreaking discovery of B. infantis EVC001, a natural bacterial strain foundational to infant immune health. Unfortunately, B. infantis had been almost completely eradicated from infants in developed countries due to … Type: | 0 | 0 | 0 | 23 |
 | Automated Engineering Services, Inc. Solutions for Better Biotech AES (Automated Engineering Services, Inc.) was formed after recognizing gaps with most system vendors and integrators who lack a strong background in Life Science, particularly with manufacturing operations in mind. In addition to services provided, AES also manufactures their own line of rockers, pump towers and 2-15L bioreactor systems. AES is made up of world class engineers and business experts from diverse backgrounds including operations, automation consulting, DCS/PLC programming, start-up, commissioning, validation and manufacturing. In addition to our professional engineering capabilities, AES has added a top-tier business development/sales-marketing team to the organization to continue to grow … Type: | 0 | 0 | 0 | 154 |
 | Steakholder Foods Providing 3D printer systems, along with plant-based inks for crafting culinary products to empower meat manufacturers. Steakholder Foods pioneers industry-standard machinery and blends to advance plant-based food. We provide proprietary 3D printers, blends, and services to help manufacturers of all sizes reach the execution of their offerings. Leveraging 3D technology manufacturing technologies, we enable the production of plant-based food that mirrors traditional meat's taste, texture, and appearance, offering an alternative to industrial farming and fishing. Our expertise includes crafting complex textures for plant-based meat and seafood, such as beef steaks, white fish, shrimp, and eel. While initially focused on plant-based … Type: | 8 | 2 | 4 | 59 |
 | Bond Pet Foods Reimagining pet nutrition so people, pets, farm animals and the planet all win. We are an Ally For All Animals®. Reimagining meat for pet nutrition so people, pets, farm animals and the planet all win. Type: | 2 | 0 | 2 | 30 |
 | Oobli Seriously sweet proteins. We make seriously sweet proteins that are changing the world, one bite at a time. Sweetness from protein—not sugar—is the breakthrough you’ve been waiting for. They’re good for your body and good for the planet, but it’s their amazing taste that will keep you coming back. The gut-friendly, diabetic-friendly, all flavor, no compromise win we all deserve. We’re a team of biologists, engineers, food-lovers, health advocates and environmentalists on a mission to transform the world with healthy sweetness. Come join us in building a sweeter future for all. Try our NEW Sweet Tea with only 7 grams … Type: | 0 | 0 | 0 | 48 |
 | biftek.co #biftek.co produces animal-free, cost-effective cultured meat growth medium supplement. We produce microorganism-based, natural, and cost-effective growth medium supplement to grow muscle stem cells. Instead of conventional fetal-bovine-serum (FBS) dependent production, which is nearly 90% of the bill, our patent-pending formulation decreases related expenses dramatically. We introduce a much better way to cultivate affordable meat. Type: | 2 | 0 | 1 | 12 |
 | BIOMILQ Unlocking human potential with breakthrough mammary biotechnology. BIOMILQ is a women-owned and science-led mammary biotechnology start-up leveraging its patented technology to produce functional cell-cultured human milk components outside the body. With the goal of bridging the gap between breast milk and infant formula, BIOMILQ aims to revolutionize early-life nutrition by bringing more of the benefits of breast milk to more babies. Femtech, Biotechnology, infant nutrition, Social Venture, and Female Founder Type: | 2 | 1 | 0 | 26 |
 | Culture Biosciences Culture is your bioreactor lab, in the cloud. We help scientists accelerate bioprocess development with our high-throughput bioreactor cloud lab. You design your experiment, and we execute the experiment in our lab using our 250mL bioreactors. We take care of the high-quality execution so that you can focus on developing processes. While your experiment runs in our lab, you can monitor and analyze your data in real time using our online dashboard. With Culture, get faster insights to make better, data-driven decisions. Type: | 1 | 1 | 0 | 91 |
Startup